These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30825056)

  • 41. Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.
    Justus CR; Sanderlin EJ; Yang LV
    Int J Mol Sci; 2015 May; 16(5):11055-86. PubMed ID: 25988385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.
    Dougall WC
    Clin Cancer Res; 2012 Jan; 18(2):326-35. PubMed ID: 22031096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What Is Breast in the Bone?
    Shemanko CS; Cong Y; Forsyth A
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The endocrine influence on the bone microenvironment in early breast cancer.
    Wilson C; Brown H; Holen I
    Endocr Relat Cancer; 2016 Dec; 23(12):R567-R576. PubMed ID: 27687494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments.
    Wojtkowiak JW; Rothberg JM; Kumar V; Schramm KJ; Haller E; Proemsey JB; Lloyd MC; Sloane BF; Gillies RJ
    Cancer Res; 2012 Aug; 72(16):3938-47. PubMed ID: 22719070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells.
    Bezdenezhnykh N; Semesiuk N; Lykhova O; Zhylchuk V; Kudryavets Y
    Exp Oncol; 2014 Jun; 36(2):72-8. PubMed ID: 24980759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.
    Yang YH; Buhamrah A; Schneider A; Lin YL; Zhou H; Bugshan A; Basile JR
    PLoS One; 2016; 11(2):e0150151. PubMed ID: 26910109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
    Nakamura H; Hiraga T; Ninomiya T; Hosoya A; Fujisaki N; Yoneda T; Ozawa H
    J Bone Miner Metab; 2008; 26(6):642-7. PubMed ID: 18979165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
    Wang J; Rouse C; Jasper JS; Pendergast AM
    Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
    Barnes GL; Hebert KE; Kamal M; Javed A; Einhorn TA; Lian JB; Stein GS; Gerstenfeld LC
    Cancer Res; 2004 Jul; 64(13):4506-13. PubMed ID: 15231660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matricellular proteins as regulators of cancer metastasis to bone.
    Trotter TN; Yang Y
    Matrix Biol; 2016; 52-54():301-314. PubMed ID: 26807761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.
    Park SH; Keller ET; Shiozawa Y
    Calcif Tissue Int; 2018 Feb; 102(2):152-162. PubMed ID: 29094177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of bone metastasis.
    Mundy GR
    Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Bone Microenvironment: a Fertile Soil for Tumor Growth.
    Buenrostro D; Mulcrone PL; Owens P; Sterling JA
    Curr Osteoporos Rep; 2016 Aug; 14(4):151-8. PubMed ID: 27255469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer Cell Colonisation in the Bone Microenvironment.
    Kan C; Vargas G; Pape FL; Clézardin P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.